目的 从建立妊娠合并甲状腺功能减退或亢进患者药学监护流程出发,探索标准化药学监护服务模式。方法 临床药师从日常药学服务工作出发,依据循证医学、相关法律法规及临床实际情况,制定并试行药学监护流程,利用分级药学监护管理方法和标准记录表格等工具,对患者实施系统、实时、连续的药学监护工作。结果 临床药师按本流程对42例妊娠合并(亚)临床甲减或甲亢患者进行了药学监护,参与优化药物治疗方案,干预不合理用药行为,并对药物不良反应提供处置意见。结论 实施药学监护流程有利于临床药师深入开展药学服务工作,保障患者用药安全。标准化的实现可促进其在行业领域推广,并促进妇产科临床药师专业技术水平和药学服务能力的提高及同质化。
Abstract
OBJECTIVE To explore standardized pharmaceutical care service mode from establishment of process for pregnancy combined with hypothyroidism or hyperthyroidism. METHODS According to evidence-based medicine, relevant regulations and clinical practice, the pharmaceutical care process was established and tried out based on the clinical pharmacists′ daily work. We used METHODS of pharmaceutical care classification and standard record forms to carry out the systematic, real-time and continuous medical supervision work for patients. RESULTS Pharmaceutical care was performed on forty-two patients with hypothyroidism or hyperthyroidism in accordance with this procedure. Clinical pharmacists participated in the optimization of drug treatment regimens, intervened with irrational use of drugs, and advised on drug adverse reactions. CONCLUSION The practice of pharmaceutical care process is beneficial for clinical pharmacists to carry out pharmaceutical service in depth and ensure the safety of drug use. Standardization can promote this procedure in the industry field, as well as promote the improvement and homogenization of professional skill level and pharmacy service ability of clinical pharmacists in gynecology and obstetrics.
关键词
妊娠 /
甲状腺功能减退 /
甲状腺功能亢进 /
药学监护流程
{{custom_keyword}} /
Key words
pregnancy /
hypothyroidism /
hyperthyroidism /
pharmaceutical care process
{{custom_keyword}} /
中图分类号：
R969.3
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] AHMAD S, GERACI S A, KOCH C A. Thyroid disease in pregnancy: women′s health series[J]. South Med J, 2013, 106(11): 532-538.
[2] The American College of Obstetricians and GynecologistsPractice Bulletin No. 148: thyroid disease in pregnancy[J]. Obstet Gynecol, 2015, 125(4): 996-1005.
[3] ALEXANDER E K, PEARCE E N, BRENT G A, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum[J]. Thyroid, 2017, 27(3):315-389.
[4] Chinese Society of Endocinology, Chinese Society of Perinatal Medicine. Guidelines for the Diagnosis and Treatment of Thyroid Diseases in Pregnancy and Postpartum[J]. Chin J Perinat Med(中华围产医学杂志), 2012, 15(7): 385-403.
[5] COUCH K A, GEIDE T. ASHP Therapeutic position statement on strategies for identifying and preventing pneumococcal resistance[J]. Am J Health Syst Pharm, 2014, 71(5):417-424.
[6] TANG H B, JIANG M, ZHOU J Y, et al. Key support study of medical staff for obstetric on pharmaceutical service pathway for pregnant and delivery women[J]. Chin Pharm J(中国药学杂志), 2014,49(24): 2230-2233.
[7] LUO L F, DAI H B. Literature analysis on pharmaceutical care in China[J]. Chin Hosp Pharm J (中国医院药学杂志), 2017,37(4):319-321.
[8] SUN F Y, LIU T. Research status and analysis of graded nursing in China[J]. Nur Pract Res(护理实践与研究), 2017, 14(8): 27-29.
[9] BU Y S, XU Y G, CHEN F, et al. Study on development and implementation of grading pharmaceutical care[J]. Chin Hosp Pharm J (中国医院药学杂志), 2015,35(24):2163-2165.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
上海市卫生计生委药政处临床药学重点专科项目资助[沪卫计药政(2017)5号]
{{custom_fund}}
PDF(978 KB)
